Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.98−0.03 (-3.28%)
Close on Nov 18, 2026Market cap $18.82MP/E –Yield –
Cocrystal Pharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Cocrystal Pharma's price to sales ratio was 41.3× on Apr 30, 2021, against 5.0× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Apr 30, 2021 | 41.3× | −7.7 |
| 2020 | Dec 31, 2020 | 48.9× | – |
See a number that looks wrong?